Cargando…

Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing

BACKGROUND: BCR::ABL1 fusion has significant prognostic value and is screened for chronic myeloid leukemia (CML) disease monitoring as a part of routine molecular testing. To overcome the limitations of the current standard real-time quantitative polymerase chain reaction (RQ-PCR), we designed and v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyeonah, Seo, Jieun, Shin, Saeam, Lee, Seung-Tae, Choi, Jong Rak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226238/ https://www.ncbi.nlm.nih.gov/pubmed/37248544 http://dx.doi.org/10.1186/s12935-023-02938-2

Ejemplares similares

Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
por: Ha, Jihye, et al.
Publicado: (2016)

Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia
por: Shin, Saeam, et al.
Publicado: (2017)

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms
por: Kim, Borahm, et al.
Publicado: (2019)

A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia
por: Lyu, Xiaodong, et al.
Publicado: (2016)

BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
por: Mroczkowska-Bękarciak, Aleksandra, et al.
Publicado: (2023)

Next-Generation Sequencing in Korean Children With Autism Spectrum Disorder and Comorbid Epilepsy
por: Lee, Junghan, et al.
Publicado: (2020)

Induction of BCR‐ABL Fusion Genes by in vitro X‐irradiation
por: Ito, Takashi, et al.
Publicado: (1993)

Two Cases of Acute Lymphoblastic Leukemia with an e1a3 BCR-ABL1 Fusion Transcript
por: Shin, Sang-Yong, et al.
Publicado: (2015)

Precision Medicine through Next-Generation Sequencing in Inherited Eye Diseases in a Korean Cohort
por: Moon, Dabin, et al.
Publicado: (2021)

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients
por: Soverini, Simona, et al.
Publicado: (2016)

The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia
por: Rafiei, Anahita, et al.
Publicado: (2015)

Genetic spectrum and characteristics of autosomal optic neuropathy in Korean: Use of next-generation sequencing in suspected hereditary optic atrophy
por: Seo, Yuri, et al.
Publicado: (2022)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Diagnostic yield of targeted next-generation sequencing for pediatric hereditary hemolytic anemia
por: Choi, Yu Jeong, et al.
Publicado: (2023)

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing
por: Linhartova, Jana, et al.
Publicado: (2015)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET
por: Shibata, Yoshiyuki, et al.
Publicado: (2010)

t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia
por: Kim, Jieun, et al.
Publicado: (2016)

Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia
por: Kim, Jieun, et al.
Publicado: (2016)

The e8a2 fusion transcript in B lymphoblastic leukemia with BCR-ABL1 rearrangement
por: Kim, Min Jin, et al.
Publicado: (2012)

Cryptic e1a2 BCR-ABL1 Fusion With Complex Chromosomal Abnormality in de novo Myelodysplastic Syndrome
por: Seo, Bo-Young, et al.
Publicado: (2015)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Kawakami, Shohei, et al.
Publicado: (2022)

Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells
por: Bucur, Octavian, et al.
Publicado: (2013)

BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility
por: Zheng, Xiaomin, et al.
Publicado: (2006)

Philadelphia Chromosome‐positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes
por: Ohyashiki, Kazuma, et al.
Publicado: (1990)

AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax
por: Low, Soon Khai, et al.
Publicado: (2022)

A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase
por: Park, Sang Hyuk, et al.
Publicado: (2013)

BCR: a new target in resistance mediated by BCR/ABL-315I?
por: Haberbosch, Isabella, et al.
Publicado: (2016)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins
por: You, Liangshun, et al.
Publicado: (2016)

Deletion of 20p13 and Duplication of 20p13p12.3 in a Patient with Delayed Speech and Development
por: Kwon, Soon Sung, et al.
Publicado: (2018)

Expanding the Diversity of Allosteric Bcr-Abl Inhibitors
por: Deng, Xianming, et al.
Publicado: (2010)

An In-House Method for Molecular Monitoring of BCR-ABL
por: Sercan, Hakkı Ogün, et al.
Publicado: (2012)

Depression of oncogenecity by dephosphorylating and degrading BCR-ABL
por: Gao, Miao, et al.
Publicado: (2016)

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
por: Soverini, Simona, et al.
Publicado: (2019)

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
por: Zhou, Liang L., et al.
Publicado: (2008)

The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
por: Zeng, Dachuan, et al.
Publicado: (2022)

Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients
por: Osman, Emad-Aldin I., et al.
Publicado: (2010)

BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran
por: Ayatollahi, Hossein, et al.
Publicado: (2018)

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
por: Boer, Judith M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_el8gflvtfh8v396ttci9gnc2ri